A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378

NCT05741437 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes

Interventions

DRUG: CKD-378, QD, PO Drug: D745, D150, QD, PO

Sponsor

Chong Kun Dang Pharmaceutical